Moderna, Inc.
MRNA
$49.04
-$0.99-1.98%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.34B | -826.00M | -200.00M | -825.00M | -971.00M |
| Total Depreciation and Amortization | 59.00M | 67.00M | 52.00M | 57.00M | 39.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 101.00M | 130.00M | 119.00M | 146.00M | 106.00M |
| Change in Net Operating Assets | 553.00M | 1.56B | -818.00M | -297.00M | -211.00M |
| Cash from Operations | -630.00M | 930.00M | -847.00M | -919.00M | -1.04B |
| Capital Expenditure | -62.00M | -39.00M | -33.00M | -3.00M | -117.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.00M | -9.00M | 733.00M | 567.00M | 847.00M |
| Cash from Investing | -76.00M | -48.00M | 700.00M | 564.00M | 730.00M |
| Total Debt Issued | -- | 600.00M | -- | -2.00M | 2.00M |
| Total Debt Repaid | -- | -12.00M | -3.00M | -3.00M | -- |
| Issuance of Common Stock | 19.00M | 16.00M | 2.00M | 14.00M | 3.00M |
| Repurchase of Common Stock | -2.00M | -1.00M | 0.00 | 0.00 | -1.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -22.00M | -- | -- | -- |
| Cash from Financing | 17.00M | 581.00M | -1.00M | 9.00M | 4.00M |
| Foreign Exchange rate Adjustments | 1.00M | 0.00 | 1.00M | 1.00M | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -688.00M | 1.46B | -147.00M | -345.00M | -303.00M |